Thursday, January 29, 2015
Go to Market Reports.com
Efficient Delivery of siRNA in Human Renal Cell Carcinoma Cell Line Us
FabRICATOR® - perfect F(ab?)2 fragments in minutes
First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Ce
Knockdown of BACE-1, an Alzheimer’s Disease Drug Target, with NIMT®FeO
Measurement of Proteasome Inhibition in Live Cells in Molecular Device
NIMT®FeOfection|PURPLE in siRNA Delivery into HEK293 Cells
Nucleofection® Enables Luciferase Reporter Assays in Primary Cells and
Optimized cell culture
Tecan Group Ltd.
RNAi-mediated CD2 suppression in primary human T cells
showing results 10 to 18 of 22
“Unprecedented Sensitivity and Specificity” in Ovarian Cancer
Study of the use of the Parsortix system as a clinical application in the detection and treatment of ovarian cancer patients.
Cancer-Causing Virus Blocks Human Immune Response
Epstein-Barr virus shown to outwit the human immune response using microRNAs.
Major Study Links Gene to Drug Resistance in Testicular Cancer
Researchers used a genetic technique called whole-exome sequencing to examine tumour samples.
New Blood Test For Aggressive Bone Cancer
Researchers at the University of East Anglia are developing a simple blood test to diagnose bone cancer thanks to funding from the Big C.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Tumor Suppressor Protein Plays Key Role In Maintaining Immune Balance
St. Jude Children’s Research Hospital scientists show that the PTEN tumor suppressor protein is essential for proper regulatory T cell function; discovery offers new focus for improving treatment of autoimmune diseases.
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Bad Luck of Random Mutations Plays Predominant Role in Cancer, Study Shows
Statistical modeling links cancer risk with number of stem cell divisions.
3-D Culture System for Pancreatic Cancer has Potential to Change Therapeutic Approaches
Organoid technology with human tissue provides a model for full progression of the disease.
Targeting The Cell’s ‘Biological Clock’
Researchers target the cell’s ‘biological clock’ in promising new therapy to kill cancer cells, shrink tumor growth.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.